The max network gone mad

Molecular and Cellular Biology

Volumn 21, Issue 3, 2001, Pages 691-702

  Baudino, T A ^a   Cleveland, J L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN MAD1; PROTEIN MAD2;

GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; GENE TARGETING; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE TARGETING; GENES, MYC; GENES, TUMOR SUPPRESSOR; HELIX-LOOP-HELIX MOTIFS; HUMANS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEOPLASMS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 0035133142     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.3.691-702.2001     Document Type: Short Survey

References (145)

1. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
2. myc oncogenes: Activation and amplification
3. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
4. Oncogenic activity of the c-Myc protein requires dimerization with Max
5. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max
6. Myc-Max-Mad: A transcription factor network controlling cell cycle progression, differentiation, and death
7. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max
8. Functional role of c-myc in mitogenic response to platelet-derived growth factor
9. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis
10. A switch from Myc:Max to Mad: Max heterocomplexes accompanies monocyte/macrophage differentiation
11. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
12. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3
13. Mxil tumor suppressor gene is not mutated in primary pancreatic adenocarcinoma
14. The ornithine decarboxylase gene is a transcriptional target of c-Myc
15. Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers
16. max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors
17. Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial patterning, and skeletal muscle development
18. Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors
19. Apoptotic cell death induced by c-myc is inhibited by bcl-2
20. Binding of myc proteins to canonical and noncanonical DNA sequences
21. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA binding complex with Myc
22. Myc and Max associate in vivo
23. Control of cell proliferation by Myc
24. Coexamination of site-specific transcription factor binding and promoter activity in living cells
25. Angiogenesis is an early event in the generation of myc-induced lymphomas
26. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene
27. c-MYC interacts with IN11/hSNF5 and requires the SWl/SNF complex for transactivation function
28. The INK4a/ARF tumor suppressor: One gene - Two products - Two pathways
29. Heterodimers of the SnoN and Ski oncoproteins form preferentially over homodimers and are more potent transforming agents
30. The ski oncogene induces muscle differentiation in quail embryo cells
31. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment
32. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle
33. c-Myc target genes involved in cell growth, apoptosis, and metabolism
34. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice
35. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo
36. Mutation of the MXI1 gene in prostate cancer
37. Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation
38. No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters
39. A 13-amino acid amphipathic alpha-helix is required for the functional interaction between the transcriptional repressor Mad1 and mSin3A
40. The MYC protein activates transcription of the a-prothymosin gene
41. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
42. The role of c-myc in cell growth
43. Induction of apoptosis in fibroblasts by c-myc protein
44. The molecular role of Myc in growth and transformation: Recent discoveries lead to new insights
45. Myc boxes, which are conserved in Myc family proteins, are signals for protein degradation via the proteasome
46. Lack of deletions of PTEN/MMAC1 and MXI1 loci in renal cell carcinoma by interphase cytogenetics
47. The Myc/Max/Mad network and the transcriptional control of cell behavior
48. c-Myc proteolysis by the ubiquitinproteosome pathway: Stabilization of c-Myc in Burkitt's lymphoma cells
49. Mmip1: A novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc
50. Effects of c-myc expression on cell cycle progression
51. Sin3 corepressor function in Myc-induced transcription and transformation
52. Histone deacetylase activity is required for full transcriptional repression by mSin3A
53. Expression and activity of L-Myc in normal mouse development
54. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1
55. A complex containing N-CoR, mSin3, and histone deacetylase mediates transcriptional repression
56. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential
57. Proteins of the Myc network: Essential regulators of cell growth and differentiation
58. PTEN and MXI1 allelic loss on chromosome 10q is rare in melanoma in vivo
59. The T genes in embryogenesis
60. A comparative analysis of N-myc and c-myc expression and cellular proliferation in mouse organogenesis
61. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis
62. Mnt, a novel Max-interacting protein, is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites
63. Mad3 and Mad4: Novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation
64. Mga, a dual specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif
65. Differential modulation of cyclin gene expression by MYC
66. Combinatorial roles of the nuclear receptor corepressor in transcription and development
67. Drosophila myc regulates cellular growth during development
68. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
69. Max: Functional domains and interaction with c-Myc
70. Point mutations of the Mxil gene are rare in prostate cancers
71. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platlet-derived growth factor
72. Sequence-specific DNA binding by Myc proteins
73. Identifications of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer
74. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions
75. Myc and Max proteins possess distinct transcriptional activities
76. The Mxi1 tumor supressor gene is not mutated in primary prostate cancer
77. SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors
78. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression
79. The c-myc oncogene perturbs B lymphocyte development in E m-myc transgenic mice
80. Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development
81. Mxi1 mutations in human neurofibrosarcomas
82. Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene
83. Overexpressed max is not oncogenic and attenuates myc-induced lymphoproliferation and lymphomagenesis in transgenic mice
84. Max and c-Myc/Max DNA-binding activities in cell extracts
85. Alternative forms of Max as enhancers or suppressors of Myc-Ras cotransformation
86. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation
87. The RXR heterodimers and orphan receptors
88. Myc function and regulation
89. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins
90. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
91. Mlx, a new Max-like bHLHZip family member: The center stage of a novel transcription factor regulatory pathway?
92. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box, and acts as a transcriptional repressor
93. Genetics of programmed cell death in C. elegans: Past, present, and future
94. 1/S-phase boundary is suppressed by inhibitory c-Myc mutants
95. Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus
96. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes
97. Association of specific DNA binding and transcriptional repression with the transforming and myogenic activities of c-Ski
98. Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma
99. Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor
100. Myc-enhanced expression of Culi promotes ubiquitin-dependent proteolysis and cell cycle progression
101. Gene-target recognition among members of the Myc superfamily and implications for oncogenesis
102. c-Myc and apoptosis
103. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways
104. c-Myc induces apoptosis and cell cycle progression by seperable, yet overlapping, pathways
105. The T-box gene family
106. SnoI, a novel alternatively spliced isoform of the ski protooncogene homolog, sno
107. Proto-oncogene Sno expression, alternative isoforms and immediate early serum response
108. Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion
109. Cloning and characterization of the murine homolog of the sno proto-oncogene reveals a novel splice variant
110. The Drosophila Sin3 gene encodes a widely distributed transcription factor essential for embryonic viability
111. An alternative pathway for gene regulation by Myc
112. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
113. Myc structure and function
114. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation
115. Commonly occurring loss and mutation of the MXI1 gene in prostate cancer
116. 1 progression in murine erythroleukemia cells
117. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo
118. Sequential expression of the MAD family of transcriptional repressors during differentiation and development
119. Targeted deletion of the S-phase specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis
120. Dwarfism and dysregulated proliferation in mice overexpressing the MYC antagonist MAD1
121. Max interacting protein 1: Loss of heterozygosity is frequent in desmoplastic melanoma
122. N-myc transgene promotes B lymphoid proliferation, elicts lymphomas and reveals cross-regulation with c-myc
123. New Myc-interacting proteins: A second Myc network emerges
124. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse
125. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3
126. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth
127. Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype
128. The tumor suppressor protein p16INK4a
129. Essential role for Max in early embryonic growth and development
130. Cancer cell cycles
131. The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice
132. Deletions in the long arm of chromosome 10 in lymphomas with t(14;18): A pathogenetic role of the tumor suppressor genes PTEN/MMAC and MXI1
133. T-box genes: What they do and how they do it
134. Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers
135. Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators
136. Analysis of the Max-binding protein MNT in human medulloblastomas
137. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop
138. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip is abrogated by c-Myc
139. Targeted expression of MYCN causes neuroblastoma in transgenic mice
140. Yeast SNFISWI transcriptional activators and the SPT/SIN chromatin connection
141. Lack of transcriptional repression by Max homodimers
142. Mmip-2, a novel RING finger protein that interacts with Mad members of the Myc oncoprotein network
143. Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites
144. SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex
145. Differential expression of myc family genes durning murine development